Notice: This company has been marked as potentially delisted and may not be actively trading. Xyratex (XRTX) Competitors Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsCompetitorsEarningsHeadlinesShort InterestTrends XRTX vs. MBIO, KPRX, CDT, QNTM, AYTU, JAGX, ONCO, ADXN, RDHL, and VINCShould you be buying Xyratex stock or one of its competitors? The main competitors of Xyratex include Mustang Bio (MBIO), Kiora Pharmaceuticals (KPRX), Conduit Pharmaceuticals (CDT), Quantum Biopharma (QNTM), Aytu BioPharma (AYTU), Jaguar Health (JAGX), Onconetix (ONCO), Addex Therapeutics (ADXN), RedHill Biopharma (RDHL), and Vincerx Pharma (VINC). These companies are all part of the "pharmaceutical preparations" industry. Xyratex vs. Mustang Bio Kiora Pharmaceuticals Conduit Pharmaceuticals Quantum Biopharma Aytu BioPharma Jaguar Health Onconetix Addex Therapeutics RedHill Biopharma Vincerx Pharma Mustang Bio (NASDAQ:MBIO) and Xyratex (NASDAQ:XRTX) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their community ranking, media sentiment, analyst recommendations, profitability, valuation, institutional ownership, dividends, risk and earnings. Does the MarketBeat Community believe in MBIO or XRTX? Mustang Bio received 13 more outperform votes than Xyratex when rated by MarketBeat users. Likewise, 64.26% of users gave Mustang Bio an outperform vote while only 63.41% of users gave Xyratex an outperform vote. CompanyUnderperformOutperformMustang BioOutperform Votes16964.26% Underperform Votes9435.74% XyratexOutperform Votes15663.41% Underperform Votes9036.59% Does the media favor MBIO or XRTX? In the previous week, Mustang Bio had 3 more articles in the media than Xyratex. MarketBeat recorded 3 mentions for Mustang Bio and 0 mentions for Xyratex. Xyratex's average media sentiment score of 0.00 beat Mustang Bio's score of -0.21 indicating that Xyratex is being referred to more favorably in the news media. Company Overall Sentiment Mustang Bio Neutral Xyratex Neutral Which has more risk & volatility, MBIO or XRTX? Mustang Bio has a beta of 1.92, meaning that its stock price is 92% more volatile than the S&P 500. Comparatively, Xyratex has a beta of 0.7, meaning that its stock price is 30% less volatile than the S&P 500. Which has preferable earnings & valuation, MBIO or XRTX? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMustang BioN/AN/A-$51.60M-$1.56-0.13XyratexN/AN/A-$2.16MN/AN/A Do analysts recommend MBIO or XRTX? Mustang Bio presently has a consensus target price of $2.00, suggesting a potential upside of 862.00%. Xyratex has a consensus target price of $14.00, suggesting a potential upside of 1,006.72%. Given Xyratex's higher possible upside, analysts clearly believe Xyratex is more favorable than Mustang Bio.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Mustang Bio 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Xyratex 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is MBIO or XRTX more profitable? Xyratex's return on equity of -146.27% beat Mustang Bio's return on equity.Company Net Margins Return on Equity Return on Assets Mustang BioN/A -1,243.22% -172.89% Xyratex N/A -146.27%-86.83% Do insiders and institutionals have more ownership in MBIO or XRTX? 10.0% of Mustang Bio shares are held by institutional investors. Comparatively, 0.2% of Xyratex shares are held by institutional investors. 0.8% of Mustang Bio shares are held by company insiders. Comparatively, 6.9% of Xyratex shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. SummaryXyratex beats Mustang Bio on 6 of the 11 factors compared between the two stocks. Ad Desko DigitalCentral Bank Abandons USDYou know what doesn't care about elections? Gold. If you want to protect your savings & retirement from our exploding national debt, VOTE FOR GOLD! Get Your FREE Gold Investor Kit NOW! Get Xyratex News Delivered to You Automatically Sign up to receive the latest news and ratings for XRTX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart XRTX vs. The Competition Export to ExcelMetricXyratexPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.53M$6.58B$5.15B$8.84BDividend YieldN/A8.11%5.00%4.07%P/E RatioN/A10.97126.4617.62Price / SalesN/A363.551,231.1486.42Price / CashN/A52.5940.2336.27Price / Book1.1810.176.946.36Net Income-$2.16M$153.36M$119.54M$225.88M Xyratex Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)XRTXXyratex1.5793 of 5 stars$1.27flat$14.00+1,006.7%-50.8%$2.53MN/A0.00N/AMBIOMustang Bio1.9495 of 5 stars$0.21flat$2.00+862.0%-86.4%$9.93MN/A-0.13100KPRXKiora Pharmaceuticals2.9952 of 5 stars$3.31-3.2%$10.00+202.1%-34.3%$9.93MN/A0.0010CDTConduit PharmaceuticalsN/A$0.10+10.8%N/A-92.1%$9.81MN/A0.003News CoverageGap UpHigh Trading VolumeQNTMQuantum BiopharmaN/A$5.10+1.4%N/AN/A$9.79MN/A-0.33N/AAYTUAytu BioPharma1.3155 of 5 stars$1.51+1.3%N/A-38.4%$9.28M$81M-1.21160JAGXJaguar Health0.6958 of 5 stars$0.97-1.0%N/A-95.3%$8.96M$9.76M0.0050ONCOOnconetix0.209 of 5 stars$1.15+6.5%N/AN/A$8.96M$1.46M0.0012ADXNAddex Therapeutics2.8123 of 5 stars$8.25+11.8%$30.00+263.6%+42.0%$8.75M$1.83M-5.0330RDHLRedHill Biopharma0.9699 of 5 stars$6.74+5.3%N/A-96.6%$8.63M$6.53M0.00210News CoverageVINCVincerx Pharma3.3113 of 5 stars$0.26-7.2%$2.00+681.3%-62.0%$8.59MN/A-0.2560 Related Companies and Tools Related Companies MBIO Alternatives KPRX Alternatives CDT Alternatives QNTM Alternatives AYTU Alternatives JAGX Alternatives ONCO Alternatives ADXN Alternatives RDHL Alternatives VINC Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:XRTX) was last updated on 11/22/2024 by MarketBeat.com Staff From Our Partners[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredWhat Comes Next Could Be a Once-in-a-Lifetime OpportunityA wave of technological and financial transformation is reshaping the investment landscape. For those who unde...InvestorPlace | SponsoredThe AI Crash Begins November 30thMost AI stocks are doomed. I’m not an AI hater. AI will absolutely continue to be the most disruptive tech...Brownstone Research | SponsoredThe Biggest Post-Election Market Shift Ever?Our No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | SponsoredMy favorite credit card just increased its sign-up bonusTired of getting average credit card rewards? This credit card just increased its sign-up bonus to 75,000 bonu...Card Ratings | SponsoredFirst JFK… next Elon?Today, I have another controversial prediction. One which I will take no pleasure in seeing come true. ...Porter & Company | SponsoredTech funds are hemorrhaging cash: Sell this stock nowSomething very strange is happening to U.S. stocks following President Trump's victory... And this could s...Chaikin Analytics | Sponsored[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Xyratex Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Share Xyratex With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
